Insmed Inc
INSM107.280USD
+2.100+2.00%
收盤 07/31, 16:00（美東）報價延遲15分鐘
19.51B總市值
虧損本益比TTM
關於 Insmed Inc 公司
Insmed Incorporated 是一家全球生物製藥公司。該公司正在推進一系列已獲批准和中後期研究藥物以及藥物發現。其先進的項目涉及肺部和炎症疾病，包括一種在美國、歐洲和日本獲批的治療慢性、衰弱性肺病的療法。該公司的臨牀前研究項目涵蓋廣泛的技術和模式，包括基因治療、人工智能驅動的蛋白質工程、蛋白質製造、RNA 末端連接和合成救援。其首款商業產品 ARIKAYCE（阿米卡星脂質體吸入混懸液）用於治療鳥分枝桿菌複合體 (MAC) 肺病，作爲聯合抗菌藥物方案的一部分，用於治療治療選擇有限或沒有替代治療方案的成人患者。其產品線包括臨牀階段項目、brensocatib、TPIP 和 INS1201 以及臨牀前研究項目。
公司簡介
公司代碼INSM
公司名稱Insmed Inc
上市日期Feb 15, 1991
成立日期1999
CEOMr. William H. (Will) Lewis, J.D.
員工數量1271
證券類型Ordinary Share
年結日Feb 15
公司地址700 Us Highway 202/206
城市BRIDGEWATER
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編08807
電話19089779900
網址https://insmed.com/
公司代碼INSM
上市日期Feb 15, 1991
成立日期1999
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
346.34K
+1.13%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
50.55K
-19.88%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Dr. Martina Flammer, M.D.
Dr. Martina Flammer, M.D.
Chief Medical Officer
Chief Medical Officer
4.27K
-66.30%
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Chief Financial Officer
Chief Financial Officer
239.00
-98.89%
Mr. Leo Lee
Mr. Leo Lee
Independent Director
Independent Director
--
--
Mr. Bryan Dunn
Mr. Bryan Dunn
Vice President, Investor Relations
Vice President, Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
346.34K
+1.13%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
50.55K
-19.88%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
暫無數據
地區USD
名稱
營收
佔比
US
64.28M
69.24%
Japan
22.08M
23.79%
Europe and rest of worldld
6.46M
6.96%
業務
地區
暫無數據
股東統計
更新時間: 7月30日 週三
更新時間: 7月30日 週三
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.61%
Darwin Global Management Ltd
8.12%
BlackRock Institutional Trust Company, N.A.
6.85%
T. Rowe Price Associates, Inc.
6.73%
Capital International Investors
3.79%
Other
64.90%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.61%
Darwin Global Management Ltd
8.12%
BlackRock Institutional Trust Company, N.A.
6.85%
T. Rowe Price Associates, Inc.
6.73%
Capital International Investors
3.79%
Other
64.90%
股東類型
持股股東
佔比
Investment Advisor
55.52%
Investment Advisor/Hedge Fund
27.12%
Hedge Fund
21.95%
Research Firm
1.97%
Sovereign Wealth Fund
0.97%
Individual Investor
0.82%
Family Office
0.75%
Pension Fund
0.66%
Venture Capital
0.66%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
799
209.50M
110.43%
-590.10K
2025Q1
804
211.64M
111.66%
-239.74K
2024Q4
767
205.04M
113.32%
-2.57M
2024Q3
712
200.94M
112.58%
+1.71M
2024Q2
657
186.57M
112.00%
+21.58M
2024Q1
564
156.59M
105.42%
-6.86M
2023Q4
544
155.47M
105.16%
-6.81M
2023Q3
515
153.95M
107.69%
-8.46M
2023Q2
506
152.37M
106.87%
-10.75M
2023Q1
511
151.28M
110.90%
-8.90M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
18.23M
9.61%
+47.77K
+0.26%
Mar 31, 2025
Darwin Global Management Ltd
15.40M
8.12%
+2.44M
+18.81%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.00M
6.85%
-170.21K
-1.29%
Mar 31, 2025
T. Rowe Price Associates, Inc.
12.76M
6.73%
+212.23K
+1.69%
Mar 31, 2025
Capital International Investors
7.20M
3.79%
+81.49K
+1.14%
Mar 31, 2025
Capital Research Global Investors
6.38M
3.36%
+63.68K
+1.01%
Mar 31, 2025
State Street Global Advisors (US)
5.75M
3.03%
-358.86K
-5.88%
Mar 31, 2025
JP Morgan Asset Management
5.41M
2.85%
+2.51M
+86.84%
Mar 31, 2025
Baker Bros. Advisors LP
5.38M
2.84%
+373.76K
+7.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.29M
2.26%
+201.59K
+4.93%
Mar 31, 2025
查看更多
持股ETF
更新時間: 7月6日 週日
更新時間: 7月6日 週日
機構名稱
佔比
BNY Mellon Innovators ETF
4.08%
Invesco Dorsey Wright Healthcare Momentum ETF
3.35%
Simplify Health Care ETF
3.07%
SPDR S&P Biotech ETF
2.59%
Franklin Genomic Advancements ETF
2.58%
VanEck Biotech ETF
2.57%
ProShares Ultra Nasdaq Biotechnology
2.09%
Virtus LifeSci Biotech Products ETF
2.06%
Direxion Daily S&P Biotech Bull 3X Shares
1.49%
Invesco Nasdaq Biotechnology ETF
1.42%
查看更多
BNY Mellon Innovators ETF
佔比4.08%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比3.35%
Simplify Health Care ETF
佔比3.07%
SPDR S&P Biotech ETF
佔比2.59%
Franklin Genomic Advancements ETF
佔比2.58%
VanEck Biotech ETF
佔比2.57%
ProShares Ultra Nasdaq Biotechnology
佔比2.09%
Virtus LifeSci Biotech Products ETF
佔比2.06%
Direxion Daily S&P Biotech Bull 3X Shares
佔比1.49%
Invesco Nasdaq Biotechnology ETF
佔比1.42%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
